|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:COL4A5-PAFAH1B1 (FusionGDB2 ID:HG1287TG5048) |
Fusion Gene Summary for COL4A5-PAFAH1B1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: COL4A5-PAFAH1B1 | Fusion gene ID: hg1287tg5048 | Hgene | Tgene | Gene symbol | COL4A5 | PAFAH1B1 | Gene ID | 1287 | 5048 |
Gene name | collagen type IV alpha 5 chain | platelet activating factor acetylhydrolase 1b regulatory subunit 1 | |
Synonyms | ASLN|ATS|ATS1|CA54 | LIS1|LIS2|MDCR|MDS|NudF|PAFAH | |
Cytomap | ('COL4A5')('PAFAH1B1') Xq22.3 | 17p13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | collagen alpha-5(IV) chaincollagen IV, alpha-5 polypeptidecollagen of basement membrane, alpha-5 chaincollagen, type IV, alpha 5dA149D17.3dA24A23.1 | platelet-activating factor acetylhydrolase IB subunit alphalissencephaly 1 proteinplatelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit (45kD)platelet-activatin | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P29400 | . | |
Ensembl transtripts involved in fusion gene | ENST00000328300, ENST00000361603, ENST00000477429, | ||
Fusion gene scores | * DoF score | 12 X 9 X 6=648 | 18 X 14 X 8=2016 |
# samples | 12 | 18 | |
** MAII score | log2(12/648*10)=-2.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/2016*10)=-3.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: COL4A5 [Title/Abstract] AND PAFAH1B1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | COL4A5(107840798)-PAFAH1B1(2585023), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | COL4A5-PAFAH1B1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. COL4A5-PAFAH1B1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. COL4A5-PAFAH1B1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. COL4A5-PAFAH1B1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | PAFAH1B1 | GO:0007017 | microtubule-based process | 11940666 |
Fusion gene breakpoints across COL4A5 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PAFAH1B1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | GBM | TCGA-06-0190-01A | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
Top |
Fusion Gene ORF analysis for COL4A5-PAFAH1B1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000328300 | ENST00000451360 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
5CDS-intron | ENST00000328300 | ENST00000572915 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
5CDS-intron | ENST00000361603 | ENST00000451360 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
5CDS-intron | ENST00000361603 | ENST00000572915 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
In-frame | ENST00000328300 | ENST00000397195 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
In-frame | ENST00000361603 | ENST00000397195 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
intron-3CDS | ENST00000477429 | ENST00000397195 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
intron-intron | ENST00000477429 | ENST00000451360 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
intron-intron | ENST00000477429 | ENST00000572915 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000328300 | COL4A5 | chrX | 107840798 | + | ENST00000397195 | PAFAH1B1 | chr17 | 2585023 | + | 5910 | 2023 | 244 | 2064 | 606 |
ENST00000361603 | COL4A5 | chrX | 107840798 | + | ENST00000397195 | PAFAH1B1 | chr17 | 2585023 | + | 5910 | 2023 | 244 | 2064 | 606 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000328300 | ENST00000397195 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + | 0.000732145 | 0.9992679 |
ENST00000361603 | ENST00000397195 | COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585023 | + | 0.000732145 | 0.9992679 |
Top |
Fusion Genomic Features for COL4A5-PAFAH1B1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585022 | + | 4.81E-07 | 0.9999995 |
COL4A5 | chrX | 107840798 | + | PAFAH1B1 | chr17 | 2585022 | + | 4.81E-07 | 0.9999995 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for COL4A5-PAFAH1B1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chrX:107840798/chr17:2585023) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
COL4A5 | . |
FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | COL4A5 | chrX:107840798 | chr17:2585023 | ENST00000328300 | + | 24 | 53 | 27_41 | 593 | 1692.0 | Region | Note=Nonhelical region (NC2) |
Hgene | COL4A5 | chrX:107840798 | chr17:2585023 | ENST00000361603 | + | 24 | 51 | 27_41 | 593 | 1686.0 | Region | Note=Nonhelical region (NC2) |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | COL4A5 | chrX:107840798 | chr17:2585023 | ENST00000328300 | + | 24 | 53 | 1461_1685 | 593 | 1692.0 | Domain | Collagen IV NC1 |
Hgene | COL4A5 | chrX:107840798 | chr17:2585023 | ENST00000361603 | + | 24 | 51 | 1461_1685 | 593 | 1686.0 | Domain | Collagen IV NC1 |
Hgene | COL4A5 | chrX:107840798 | chr17:2585023 | ENST00000328300 | + | 24 | 53 | 42_1456 | 593 | 1692.0 | Region | Note=Triple-helical region |
Hgene | COL4A5 | chrX:107840798 | chr17:2585023 | ENST00000361603 | + | 24 | 51 | 42_1456 | 593 | 1686.0 | Region | Note=Triple-helical region |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 56_82 | 386 | 411.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 7_39 | 386 | 411.0 | Domain | LisH | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 106_147 | 386 | 411.0 | Repeat | Note=WD 1 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 148_187 | 386 | 411.0 | Repeat | Note=WD 2 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 190_229 | 386 | 411.0 | Repeat | Note=WD 3 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 232_271 | 386 | 411.0 | Repeat | Note=WD 4 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 274_333 | 386 | 411.0 | Repeat | Note=WD 5 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 336_377 | 386 | 411.0 | Repeat | Note=WD 6 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 378_410 | 386 | 411.0 | Repeat | Note=WD 7 |
Top |
Fusion Gene Sequence for COL4A5-PAFAH1B1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>18374_18374_1_COL4A5-PAFAH1B1_COL4A5_chrX_107840798_ENST00000328300_PAFAH1B1_chr17_2585023_ENST00000397195_length(transcript)=5910nt_BP=2023nt AGAAGGGAAAAGTTCTCCTGAGAGACCGGCTTTGGGGAGGGGAGGGGGGAAGGAAGAGTAGCTCCTTCTTCTTCTTCTTTTTTTTTTCTT CCACTCTTAAAAAGCTTCTTTCTCTTCACCCAAGCCTCACTGTCCCTCTCCGGCTCTAGCTCTCTCCATATAAACCCTCAAGATTATGTC AATTGGTTAGAGCCAGCCGGGAATTTCGTGCGGGTGCTGAAGGAGCTGCGGGAGCCGGAGAAGAATGAAACTGCGTGGAGTCAGCCTGGC TGCCGGCTTGTTCTTACTGGCCCTGAGTCTTTGGGGGCAGCCTGCAGAGGCTGCGGCTTGCTATGGGTGTTCTCCAGGATCAAAGTGTGA CTGCAGTGGCATAAAAGGGGAAAAGGGAGAGAGAGGGTTTCCAGGTTTGGAAGGACACCCAGGATTGCCTGGATTTCCAGGTCCAGAAGG GCCTCCGGGGCCTCGGGGACAAAAGGGTGATGATGGAATTCCAGGGCCACCAGGACCAAAAGGAATCAGAGGTCCTCCTGGACTTCCTGG ATTTCCAGGGACACCAGGTCTTCCTGGAATGCCAGGCCACGATGGGGCCCCAGGACCTCAAGGTATTCCCGGATGCAATGGAACCAAGGG AGAACGTGGATTTCCAGGCAGTCCCGGTTTTCCTGGTTTACAGGGTCCTCCAGGACCCCCTGGGATCCCAGGTATGAAGGGTGAACCAGG TAGTATAATTATGTCATCACTGCCAGGACCAAAGGGTAATCCAGGATATCCAGGTCCTCCTGGAATACAAGGCCTACCTGGTCCCACTGG TATACCAGGGCCAATTGGTCCCCCAGGACCACCAGGTTTGATGGGCCCTCCTGGTCCACCAGGACTTCCAGGACCTAAGGGGAATATGGG CTTAAATTTCCAGGGACCCAAAGGTGAAAAAGGTGAGCAAGGTCTTCAGGGCCCACCTGGGCCACCTGGGCAGATCAGTGAACAGAAAAG ACCAATTGATGTAGAGTTTCAGAAAGGAGATCAGGGACTTCCTGGTGACCGAGGGCCTCCTGGACCTCCAGGGATACGTGGTCCTCCAGG TCCCCCAGGTGGTGAGAAAGGTGAGAAGGGTGAGCAAGGAGAGCCAGGCAAAAGAGGTAAACCAGGCAAAGATGGAGAAAATGGCCAACC AGGAATTCCTGGTTTGCCTGGTGATCCTGGTTACCCTGGTGAACCCGGAAGGGATGGTGAAAAGGGCCAAAAAGGTGACACTGGCCCACC TGGACCTCCTGGACTTGTAATTCCTAGACCTGGGACTGGTATAACTATAGGAGAAAAAGGAAACATTGGGTTGCCTGGGTTGCCTGGAGA AAAAGGAGAGCGAGGATTTCCTGGAATACAGGGTCCACCTGGCCTTCCTGGACCTCCAGGGGCTGCAGTTATGGGTCCTCCTGGCCCTCC TGGATTTCCTGGAGAAAGGGGTCAGAAAGGTGATGAAGGACCACCTGGAATTTCCATTCCTGGACCTCCTGGACTTGACGGACAGCCTGG GGCTCCTGGGCTTCCAGGGCCTCCTGGCCCTGCTGGCCCTCACATTCCTCCTAGTGATGAGATATGTGAACCAGGCCCTCCAGGCCCCCC AGGATCTCCAGGTGATAAAGGACTCCAAGGAGAACAAGGAGTGAAAGGTGACAAAGGTGACACTTGCTTCAACTGCATTGGAACTGGTAT TTCAGGGCCTCCAGGTCAACCTGGTTTGCCAGGTCTCCCAGGTCCTCCAGGATCTCTTGGTTTCCCTGGACAGAAAGGGGAAAAAGGACA AGCTGGTGCAACTGGTCCCAAAGGATTACCAGGCATTCCAGGAGCTCCAGGTGCTCCAGGCTTTCCTGGATCTAAAGGTGAACCTGGTGA TATCCTCACTTTTCCAGGAATGAAGGGTGACAAAGGAGAGTTGGGTTCCCCTGGAGCTCCAGGGCTTCCTGGTTTACCTGGCACTCCTGG ACAGGATGGATTGCCAGGGCTTCCTGGCCCGAAAGGAGAGCCTATTTCCACAAGACGGCACCCTATGTCGTCACTGGCAGCGTAGATCAA ACAGTAAAAGTGTGGGAGTGCCGTTGATTGTGTCTCCTTCGGCCCCTCCTCCCTCTTTTCCTCTGGATGCACTCTGATGATACCATGGTT ACCCCATTGAGCTCTGTTTAAATAAATATTGTCCTTTCATGTAAATTATTCTGGATGTAGATTGAGCTTATTAAATGTTACACACAAAGT ATTCATGCATGGTGAATCCAAATTGTATACTGTAAATTTACATACGTTGTCTAGAAGTACCATAGGGTTTAAAAACCTGGGCTGGCATTG GTCACACCAGGCCTAAGAAGGCAGAAGTTGAATCAATTGAACTAGGGCACTAAACTGAATAGTTGACAGTGTCATTTTATGTTGGATTAT TAATTCCTGTTTTTCTTTCTGCTATCTGTTGGTGCCTGACTTGATGGCCTCATTTGGGGAAAAGTGGTGGTTATTAGGGCTTTTTCTGAA ATGTGTATCTATGTAACATCACTTAAGTGTGCTTAATAAATCTTCTGTAAGGATTTTAGATGATAAGGCTACAATTCAGAATCTTCTGAA CCATCTATGTAATGAATGGGGATTATACATTGGAATTTTTGTCATGACACATTTGCCAAATCAGTAGGATATATTTGTTTTGGCAGCCTA TCACGCAGAGGCTAGTGGTATATTTATGTAAGAAAATGACTGTAAATCTCAAGAAAAATCTCAGCAGCTAATAGCAACTCATTTATTTCA TTTTGGTCTTAATGCTTTGTAAACAGGTCAAAAAATACTGTCATACTCTAAGCTTCTATTTTCCACACTGGACATACTTCTAGTTGTATT CTCCATACTATTAGACTGTGTAGTGATGTGACTTCCAAGTAGAATTTAATCTCCCCATTGAGTGTGTCATGGTACAAATCACTATTCGTT TTTGGTGTTTTTTAGGGATGTGCAATGTGCATTACATAATGACAGAAATACTGAGAAGGTTCTGTGTGCCCATTTGAAAGGAGTGGGAGG AATACAGCAGTTTGTTTTTCAACATGAATCTGATATTGATTTAAACTGTGTTTCACTTACAAGTTTTAAAAAAATGACAGGGTTTAATGG AGCGTGCATAAAAATGTACTGTTTTCACCTTTTGTTTATATGTAAATGTTTGTAAGTATATGGGCCTATCTGTAAGTGGATAAGTCTGTA TGTGTGTATCATACACATCAACCTCCATGTCCTTAGTCCTGGGTTTTTGAAAAAGTGCTAAAACGGACAAGTAGAATAAATGTTGCTGTG GAATGCCATGCTTTAGAACAAACCCTTTTTGATCTTAATGCTTCTGAAAACTAGGTCTGACTCTGGGGATTTTTTTCCAGCCGAAGGAAA ATCACTTCCGTTATGTCCCCCTCTAATTTAGCCGCTCGACATTTTACACAACCCGGATATGTTGTATATTTTGACCCAAAGTTACAGGTA GGTTTAAGAGAATTTTTAGCCATGACTTTTGGAGCACTATTCCATTGTCAGTTATTAATAAAGAATTCCATTGCTTAGCTAACCAACAGG TTTTTTTTGTTTCCAAGAGAGTTATTTGAAAAGTTAACAGAACAATGAGATAACAGTGACAGTTTAACAAAGATAAAATTCTGAACTGCG TTTTATTCATTTGTGTACTATGTGATTTTTTAAATGTCCCCTTTAGTATTTAATGGAAAATTGGTTCCTGCAAAAGACAAAGGGTGAGAG TTAGCGTCCTGTAGATACACACAGAGACTAGGCCGTATATTAACTAGAAGCAGCTTTATGTCTAGCTTGTGTCTTTTTGTTTGTTTGCTT GTTTGTTTTTAGATTCCTGAGAGATGTCTCTGGAAGGGAAAGTTTTGAGAACTAATGGCTATTTTTGAGGACAAAAATTACATCTTAAGC TAATTCCTTAAATACATACAGTAGGTGAATTTTCAGGACAATATTGCCTCACAACCCTGCTTACATTGAAAAGTCTTTTTCCCTTAGCTC TTCTGACTGGATTTTTCTACAAAAACTATGGAAAATATCTTTGTTCTTGTTTGCTGCTATTTTCTGTCCTATTTTGAGAAATATAAATAC ATAGAAATGGTGCATCTTAACATTTGTTTGTACATGTATAAATGTCTTGTATTTTAATTCATTTTTAGCATGAATTGTTTAAGGGTAAGC CACAACATCTAGAAATCACTCATAGATATTGAACAATAAAGGAGAATGGTACCGATGCAGGAGGAAGCAAGCGTGTCTTCCCCTGCAGCA CACAGCGACTTGCGTTGACAAAGGAGGAGGAAACGATTACTCTGTAAACAAAGTTATCCTTACTTGGGAGATTGCCACAGCCTGCTGCTG AGTTGAGTTACCAGACATCCTCCATGTGAGAAGCAGCGAACATTGAATCTCAGGGATGGCCCACAACTGGGTCCACATGTAATGAGCCCT GTTTAATAACGAAGGGGTGGGGGAGAGCAGTCCGTCTACAACCTGGAATCAGATTTGCAAAATTTCCTGCACTGCTGTCTGACACTGTCC TGTTGATGCCCTTTCTGACTGTGTTCTCTGTTTTCTCTGTCTGCTGTCTAACCCTGTGCCTTGCCTGGGATAAGGACAATGATGAGGTTA CTGGTTTGGATTGTAAGTAGAGGACTTTTATTAATTGGTTTAGAGGTTCACTGCTGCTTTGTCACTTTCTCAATCAAATTGGCCACTTAA GAAATAAAGAGCTGGTAGAATTGCATCCTCAGATGATTATTGACTGTGTGTGTGTGTGAAAACAGACATTCCAGTGCCACCCAAATATAT ATCTGTAACGTGCCCAAGAAATCCTAGCTGCGCTCTTGAGAGTGCATGCCATGGAGACTGGTTTAGACACCGCGTGGAGCCTAGTTGCCT GTTGTCACGGCATCTTGCACTTTAGGAGACTAAGACCGTCCTGGTTCGTCTGTGTGTGGTGTGACCAATGGTGTGCCCAGAGCACTACTC TCAAAATCACTAGTGTTAGCAAGTCGTCCCGGGCTGGGGAGCGTTCGCCGTAGTCTTTGGAAGCTTTGGCTTTAGATTTACCAAGCCCCG CCTCCCCGCTGCCAGTGCCCTGCTCTCCCGTTCGCCTCTTTCTGTTTCTGTGTGAACTTTCCCGGTAATATCACTCGTTAAATAGGTTTT CTTTAAACTTAATTAAAGAAAAACTATTTAAAGGTAAAGGATATTTTGTTGACATCGGTGGCTCGATCATCCTTAAGCAACTGAAGTTAA AATTGTTGAAGGAAAAGGCACTTAAATTGGTTACTTTCATGTCCAGCTGTATATAAGTCCAGTGTGTTCATCTAGATGACGCAAAGAATC TCCTGGTAGAGAAGCGACATGTAAAAAACTGGTGGAAAAAGGTTTTGGATTTTTTTTCCAGTGGGGTGGGGGGAGGGCAAGCTGGATTTA CAGGTCACGGCTGGACTGAATGGGCCTTTTTATCTTCCCACTGTATCATGGAAGTAGCTGCTTGCTTGTACTGTCCATCCTTCAGGCATC CCTAAAGCTCACTCTGAAGATGTTAGAGACAAACACAAACTCTTCGAGTTAAAGTTGATCCTGACACTGACATGAAGGCAAGCCTTGATT TCGTATGAACGTTGCTGAAGTGGTAATTGAGGAAAACAGTTCCCCAGATTGTTAAGAGTTCACTGAAGATATTGACACAATTTTAAAAAA TCAGTAAAGGAATGTATATAATATTGCTCTCGTGTTTTACAGTAAGATTTGTTGCTCTCAGACTGTGTAAAACAAAATTTATTCATGTTT >18374_18374_1_COL4A5-PAFAH1B1_COL4A5_chrX_107840798_ENST00000328300_PAFAH1B1_chr17_2585023_ENST00000397195_length(amino acids)=606AA_BP= MKLRGVSLAAGLFLLALSLWGQPAEAAACYGCSPGSKCDCSGIKGEKGERGFPGLEGHPGLPGFPGPEGPPGPRGQKGDDGIPGPPGPKG IRGPPGLPGFPGTPGLPGMPGHDGAPGPQGIPGCNGTKGERGFPGSPGFPGLQGPPGPPGIPGMKGEPGSIIMSSLPGPKGNPGYPGPPG IQGLPGPTGIPGPIGPPGPPGLMGPPGPPGLPGPKGNMGLNFQGPKGEKGEQGLQGPPGPPGQISEQKRPIDVEFQKGDQGLPGDRGPPG PPGIRGPPGPPGGEKGEKGEQGEPGKRGKPGKDGENGQPGIPGLPGDPGYPGEPGRDGEKGQKGDTGPPGPPGLVIPRPGTGITIGEKGN IGLPGLPGEKGERGFPGIQGPPGLPGPPGAAVMGPPGPPGFPGERGQKGDEGPPGISIPGPPGLDGQPGAPGLPGPPGPAGPHIPPSDEI CEPGPPGPPGSPGDKGLQGEQGVKGDKGDTCFNCIGTGISGPPGQPGLPGLPGPPGSLGFPGQKGEKGQAGATGPKGLPGIPGAPGAPGF -------------------------------------------------------------- >18374_18374_2_COL4A5-PAFAH1B1_COL4A5_chrX_107840798_ENST00000361603_PAFAH1B1_chr17_2585023_ENST00000397195_length(transcript)=5910nt_BP=2023nt AGAAGGGAAAAGTTCTCCTGAGAGACCGGCTTTGGGGAGGGGAGGGGGGAAGGAAGAGTAGCTCCTTCTTCTTCTTCTTTTTTTTTTCTT CCACTCTTAAAAAGCTTCTTTCTCTTCACCCAAGCCTCACTGTCCCTCTCCGGCTCTAGCTCTCTCCATATAAACCCTCAAGATTATGTC AATTGGTTAGAGCCAGCCGGGAATTTCGTGCGGGTGCTGAAGGAGCTGCGGGAGCCGGAGAAGAATGAAACTGCGTGGAGTCAGCCTGGC TGCCGGCTTGTTCTTACTGGCCCTGAGTCTTTGGGGGCAGCCTGCAGAGGCTGCGGCTTGCTATGGGTGTTCTCCAGGATCAAAGTGTGA CTGCAGTGGCATAAAAGGGGAAAAGGGAGAGAGAGGGTTTCCAGGTTTGGAAGGACACCCAGGATTGCCTGGATTTCCAGGTCCAGAAGG GCCTCCGGGGCCTCGGGGACAAAAGGGTGATGATGGAATTCCAGGGCCACCAGGACCAAAAGGAATCAGAGGTCCTCCTGGACTTCCTGG ATTTCCAGGGACACCAGGTCTTCCTGGAATGCCAGGCCACGATGGGGCCCCAGGACCTCAAGGTATTCCCGGATGCAATGGAACCAAGGG AGAACGTGGATTTCCAGGCAGTCCCGGTTTTCCTGGTTTACAGGGTCCTCCAGGACCCCCTGGGATCCCAGGTATGAAGGGTGAACCAGG TAGTATAATTATGTCATCACTGCCAGGACCAAAGGGTAATCCAGGATATCCAGGTCCTCCTGGAATACAAGGCCTACCTGGTCCCACTGG TATACCAGGGCCAATTGGTCCCCCAGGACCACCAGGTTTGATGGGCCCTCCTGGTCCACCAGGACTTCCAGGACCTAAGGGGAATATGGG CTTAAATTTCCAGGGACCCAAAGGTGAAAAAGGTGAGCAAGGTCTTCAGGGCCCACCTGGGCCACCTGGGCAGATCAGTGAACAGAAAAG ACCAATTGATGTAGAGTTTCAGAAAGGAGATCAGGGACTTCCTGGTGACCGAGGGCCTCCTGGACCTCCAGGGATACGTGGTCCTCCAGG TCCCCCAGGTGGTGAGAAAGGTGAGAAGGGTGAGCAAGGAGAGCCAGGCAAAAGAGGTAAACCAGGCAAAGATGGAGAAAATGGCCAACC AGGAATTCCTGGTTTGCCTGGTGATCCTGGTTACCCTGGTGAACCCGGAAGGGATGGTGAAAAGGGCCAAAAAGGTGACACTGGCCCACC TGGACCTCCTGGACTTGTAATTCCTAGACCTGGGACTGGTATAACTATAGGAGAAAAAGGAAACATTGGGTTGCCTGGGTTGCCTGGAGA AAAAGGAGAGCGAGGATTTCCTGGAATACAGGGTCCACCTGGCCTTCCTGGACCTCCAGGGGCTGCAGTTATGGGTCCTCCTGGCCCTCC TGGATTTCCTGGAGAAAGGGGTCAGAAAGGTGATGAAGGACCACCTGGAATTTCCATTCCTGGACCTCCTGGACTTGACGGACAGCCTGG GGCTCCTGGGCTTCCAGGGCCTCCTGGCCCTGCTGGCCCTCACATTCCTCCTAGTGATGAGATATGTGAACCAGGCCCTCCAGGCCCCCC AGGATCTCCAGGTGATAAAGGACTCCAAGGAGAACAAGGAGTGAAAGGTGACAAAGGTGACACTTGCTTCAACTGCATTGGAACTGGTAT TTCAGGGCCTCCAGGTCAACCTGGTTTGCCAGGTCTCCCAGGTCCTCCAGGATCTCTTGGTTTCCCTGGACAGAAAGGGGAAAAAGGACA AGCTGGTGCAACTGGTCCCAAAGGATTACCAGGCATTCCAGGAGCTCCAGGTGCTCCAGGCTTTCCTGGATCTAAAGGTGAACCTGGTGA TATCCTCACTTTTCCAGGAATGAAGGGTGACAAAGGAGAGTTGGGTTCCCCTGGAGCTCCAGGGCTTCCTGGTTTACCTGGCACTCCTGG ACAGGATGGATTGCCAGGGCTTCCTGGCCCGAAAGGAGAGCCTATTTCCACAAGACGGCACCCTATGTCGTCACTGGCAGCGTAGATCAA ACAGTAAAAGTGTGGGAGTGCCGTTGATTGTGTCTCCTTCGGCCCCTCCTCCCTCTTTTCCTCTGGATGCACTCTGATGATACCATGGTT ACCCCATTGAGCTCTGTTTAAATAAATATTGTCCTTTCATGTAAATTATTCTGGATGTAGATTGAGCTTATTAAATGTTACACACAAAGT ATTCATGCATGGTGAATCCAAATTGTATACTGTAAATTTACATACGTTGTCTAGAAGTACCATAGGGTTTAAAAACCTGGGCTGGCATTG GTCACACCAGGCCTAAGAAGGCAGAAGTTGAATCAATTGAACTAGGGCACTAAACTGAATAGTTGACAGTGTCATTTTATGTTGGATTAT TAATTCCTGTTTTTCTTTCTGCTATCTGTTGGTGCCTGACTTGATGGCCTCATTTGGGGAAAAGTGGTGGTTATTAGGGCTTTTTCTGAA ATGTGTATCTATGTAACATCACTTAAGTGTGCTTAATAAATCTTCTGTAAGGATTTTAGATGATAAGGCTACAATTCAGAATCTTCTGAA CCATCTATGTAATGAATGGGGATTATACATTGGAATTTTTGTCATGACACATTTGCCAAATCAGTAGGATATATTTGTTTTGGCAGCCTA TCACGCAGAGGCTAGTGGTATATTTATGTAAGAAAATGACTGTAAATCTCAAGAAAAATCTCAGCAGCTAATAGCAACTCATTTATTTCA TTTTGGTCTTAATGCTTTGTAAACAGGTCAAAAAATACTGTCATACTCTAAGCTTCTATTTTCCACACTGGACATACTTCTAGTTGTATT CTCCATACTATTAGACTGTGTAGTGATGTGACTTCCAAGTAGAATTTAATCTCCCCATTGAGTGTGTCATGGTACAAATCACTATTCGTT TTTGGTGTTTTTTAGGGATGTGCAATGTGCATTACATAATGACAGAAATACTGAGAAGGTTCTGTGTGCCCATTTGAAAGGAGTGGGAGG AATACAGCAGTTTGTTTTTCAACATGAATCTGATATTGATTTAAACTGTGTTTCACTTACAAGTTTTAAAAAAATGACAGGGTTTAATGG AGCGTGCATAAAAATGTACTGTTTTCACCTTTTGTTTATATGTAAATGTTTGTAAGTATATGGGCCTATCTGTAAGTGGATAAGTCTGTA TGTGTGTATCATACACATCAACCTCCATGTCCTTAGTCCTGGGTTTTTGAAAAAGTGCTAAAACGGACAAGTAGAATAAATGTTGCTGTG GAATGCCATGCTTTAGAACAAACCCTTTTTGATCTTAATGCTTCTGAAAACTAGGTCTGACTCTGGGGATTTTTTTCCAGCCGAAGGAAA ATCACTTCCGTTATGTCCCCCTCTAATTTAGCCGCTCGACATTTTACACAACCCGGATATGTTGTATATTTTGACCCAAAGTTACAGGTA GGTTTAAGAGAATTTTTAGCCATGACTTTTGGAGCACTATTCCATTGTCAGTTATTAATAAAGAATTCCATTGCTTAGCTAACCAACAGG TTTTTTTTGTTTCCAAGAGAGTTATTTGAAAAGTTAACAGAACAATGAGATAACAGTGACAGTTTAACAAAGATAAAATTCTGAACTGCG TTTTATTCATTTGTGTACTATGTGATTTTTTAAATGTCCCCTTTAGTATTTAATGGAAAATTGGTTCCTGCAAAAGACAAAGGGTGAGAG TTAGCGTCCTGTAGATACACACAGAGACTAGGCCGTATATTAACTAGAAGCAGCTTTATGTCTAGCTTGTGTCTTTTTGTTTGTTTGCTT GTTTGTTTTTAGATTCCTGAGAGATGTCTCTGGAAGGGAAAGTTTTGAGAACTAATGGCTATTTTTGAGGACAAAAATTACATCTTAAGC TAATTCCTTAAATACATACAGTAGGTGAATTTTCAGGACAATATTGCCTCACAACCCTGCTTACATTGAAAAGTCTTTTTCCCTTAGCTC TTCTGACTGGATTTTTCTACAAAAACTATGGAAAATATCTTTGTTCTTGTTTGCTGCTATTTTCTGTCCTATTTTGAGAAATATAAATAC ATAGAAATGGTGCATCTTAACATTTGTTTGTACATGTATAAATGTCTTGTATTTTAATTCATTTTTAGCATGAATTGTTTAAGGGTAAGC CACAACATCTAGAAATCACTCATAGATATTGAACAATAAAGGAGAATGGTACCGATGCAGGAGGAAGCAAGCGTGTCTTCCCCTGCAGCA CACAGCGACTTGCGTTGACAAAGGAGGAGGAAACGATTACTCTGTAAACAAAGTTATCCTTACTTGGGAGATTGCCACAGCCTGCTGCTG AGTTGAGTTACCAGACATCCTCCATGTGAGAAGCAGCGAACATTGAATCTCAGGGATGGCCCACAACTGGGTCCACATGTAATGAGCCCT GTTTAATAACGAAGGGGTGGGGGAGAGCAGTCCGTCTACAACCTGGAATCAGATTTGCAAAATTTCCTGCACTGCTGTCTGACACTGTCC TGTTGATGCCCTTTCTGACTGTGTTCTCTGTTTTCTCTGTCTGCTGTCTAACCCTGTGCCTTGCCTGGGATAAGGACAATGATGAGGTTA CTGGTTTGGATTGTAAGTAGAGGACTTTTATTAATTGGTTTAGAGGTTCACTGCTGCTTTGTCACTTTCTCAATCAAATTGGCCACTTAA GAAATAAAGAGCTGGTAGAATTGCATCCTCAGATGATTATTGACTGTGTGTGTGTGTGAAAACAGACATTCCAGTGCCACCCAAATATAT ATCTGTAACGTGCCCAAGAAATCCTAGCTGCGCTCTTGAGAGTGCATGCCATGGAGACTGGTTTAGACACCGCGTGGAGCCTAGTTGCCT GTTGTCACGGCATCTTGCACTTTAGGAGACTAAGACCGTCCTGGTTCGTCTGTGTGTGGTGTGACCAATGGTGTGCCCAGAGCACTACTC TCAAAATCACTAGTGTTAGCAAGTCGTCCCGGGCTGGGGAGCGTTCGCCGTAGTCTTTGGAAGCTTTGGCTTTAGATTTACCAAGCCCCG CCTCCCCGCTGCCAGTGCCCTGCTCTCCCGTTCGCCTCTTTCTGTTTCTGTGTGAACTTTCCCGGTAATATCACTCGTTAAATAGGTTTT CTTTAAACTTAATTAAAGAAAAACTATTTAAAGGTAAAGGATATTTTGTTGACATCGGTGGCTCGATCATCCTTAAGCAACTGAAGTTAA AATTGTTGAAGGAAAAGGCACTTAAATTGGTTACTTTCATGTCCAGCTGTATATAAGTCCAGTGTGTTCATCTAGATGACGCAAAGAATC TCCTGGTAGAGAAGCGACATGTAAAAAACTGGTGGAAAAAGGTTTTGGATTTTTTTTCCAGTGGGGTGGGGGGAGGGCAAGCTGGATTTA CAGGTCACGGCTGGACTGAATGGGCCTTTTTATCTTCCCACTGTATCATGGAAGTAGCTGCTTGCTTGTACTGTCCATCCTTCAGGCATC CCTAAAGCTCACTCTGAAGATGTTAGAGACAAACACAAACTCTTCGAGTTAAAGTTGATCCTGACACTGACATGAAGGCAAGCCTTGATT TCGTATGAACGTTGCTGAAGTGGTAATTGAGGAAAACAGTTCCCCAGATTGTTAAGAGTTCACTGAAGATATTGACACAATTTTAAAAAA TCAGTAAAGGAATGTATATAATATTGCTCTCGTGTTTTACAGTAAGATTTGTTGCTCTCAGACTGTGTAAAACAAAATTTATTCATGTTT >18374_18374_2_COL4A5-PAFAH1B1_COL4A5_chrX_107840798_ENST00000361603_PAFAH1B1_chr17_2585023_ENST00000397195_length(amino acids)=606AA_BP= MKLRGVSLAAGLFLLALSLWGQPAEAAACYGCSPGSKCDCSGIKGEKGERGFPGLEGHPGLPGFPGPEGPPGPRGQKGDDGIPGPPGPKG IRGPPGLPGFPGTPGLPGMPGHDGAPGPQGIPGCNGTKGERGFPGSPGFPGLQGPPGPPGIPGMKGEPGSIIMSSLPGPKGNPGYPGPPG IQGLPGPTGIPGPIGPPGPPGLMGPPGPPGLPGPKGNMGLNFQGPKGEKGEQGLQGPPGPPGQISEQKRPIDVEFQKGDQGLPGDRGPPG PPGIRGPPGPPGGEKGEKGEQGEPGKRGKPGKDGENGQPGIPGLPGDPGYPGEPGRDGEKGQKGDTGPPGPPGLVIPRPGTGITIGEKGN IGLPGLPGEKGERGFPGIQGPPGLPGPPGAAVMGPPGPPGFPGERGQKGDEGPPGISIPGPPGLDGQPGAPGLPGPPGPAGPHIPPSDEI CEPGPPGPPGSPGDKGLQGEQGVKGDKGDTCFNCIGTGISGPPGQPGLPGLPGPPGSLGFPGQKGEKGQAGATGPKGLPGIPGAPGAPGF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for COL4A5-PAFAH1B1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 388_410 | 386.3333333333333 | 411.0 | NDEL1 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 367_409 | 386.3333333333333 | 411.0 | DCX | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 83_410 | 386.3333333333333 | 411.0 | dynein and dynactin | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 1_66 | 386.3333333333333 | 411.0 | NDE1 | |
Tgene | PAFAH1B1 | chrX:107840798 | chr17:2585023 | ENST00000397195 | 9 | 11 | 1_102 | 386.3333333333333 | 411.0 | NDEL1 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for COL4A5-PAFAH1B1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for COL4A5-PAFAH1B1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | COL4A5 | C4746986 | ALPORT SYNDROME 1, X-LINKED | 24 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | COL4A5 | C1567741 | Alport Syndrome | 12 | CLINGEN;GENOMICS_ENGLAND |
Hgene | COL4A5 | C0017668 | Focal glomerulosclerosis | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C0018965 | Hematuria | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C0033687 | Proteinuria | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C0086533 | Leiomyoma, Epithelioid | 1 | CTD_human |
Hgene | COL4A5 | C0241908 | Hematuria, Benign Familial | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C1384666 | hearing impairment | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C1567742 | Alport Syndrome, X-Linked | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C1567743 | Alport Syndrome, Autosomal Dominant | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C1567744 | Alport Syndrome, Autosomal Recessive | 1 | GENOMICS_ENGLAND |
Hgene | COL4A5 | C1839884 | Leiomyomatosis, esophageal and vulval, with nephropathy | 1 | ORPHANET |
Hgene | COL4A5 | C4049702 | Focal Segmental Glomerulosclerosis, Not Otherwise Specified | 1 | GENOMICS_ENGLAND |
Tgene | C0431375 | Classical Lissencephaly | 9 | GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C0036341 | Schizophrenia | 1 | PSYGENET | |
Tgene | C0265219 | Miller Dieker syndrome | 1 | ORPHANET | |
Tgene | C0596263 | Carcinogenesis | 1 | CTD_human | |
Tgene | C1848201 | Subcortical Band Heterotopia | 1 | GENOMICS_ENGLAND;ORPHANET | |
Tgene | C2750748 | Chromosome 17p13.3 Duplication Syndrome | 1 | ORPHANET |